Leave-behind for the launch of a biosimilar

Mundipharma belongs to a global network of independent companies, and is one of Switzerland’s top 30 pharmaceutical companies offering original products. Mundipharma also recently began marketing biosimilars.

Puls worked with the customer to develop and produce various materials for the launch of Mundipharma’s first biosimilar in Switzerland. The leave-behind took the form of an envelope featuring the campaign’s key visuals and containing some individual information sheets, each focusing on a particular topic. This concept offers flexibility and allows for subsequent expansion and additions. Target group: specialists.


Mundipharma Medical Company

Target group


  • Strategic consulting
  • Concept and creation
  • Graphic design
  • Coordination of translation
  • Coordination of production
If you click "OK”, you will leave the Puls AG website. Please note that Puls AG is not responsible for the content of the linked page. Do you want to go to the external page?